SEC filings · REGN

Regeneron Pharmaceuticals SEC filings

Every annual report, quarterly report, proxy statement and current report Regeneron Pharmaceuticals has filed with the SEC since 2026, each linked to the original on SEC EDGAR. Filing.fyi links to the SEC; it does not host copies.

Annual reports (10-K)

Quarterly reports (10-Q)

Proxy statements (DEF 14A)

Current reports (8-K)

Insider transactions (Form 4)

Holdings reports this company filed (13F)

Show 1 holdings report
  • Aug 7, 2026
    13F-HR
    Investments this company holds, quarterly report (13F)

Source: SEC EDGAR. Open REGN on EDGAR →